A citation-based method for searching scientific literature

R S Smith. Med Hypotheses 1991
Times Cited: 598







List of co-cited articles
1312 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A meta-analysis of cytokines in major depression.
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, Helena Liu, Lauren Sham, Elyse K Reim, Krista L Lanctôt. Biol Psychiatry 2010
40

From inflammation to sickness and depression: when the immune system subjugates the brain.
Robert Dantzer, Jason C O'Connor, Gregory G Freund, Rodney W Johnson, Keith W Kelley. Nat Rev Neurosci 2008
35


Evidence for an immune response in major depression: a review and hypothesis.
M Maes. Prog Neuropsychopharmacol Biol Psychiatry 1995
679
25

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.
Andrew H Miller, Vladimir Maletic, Charles L Raison. Biol Psychiatry 2009
24

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
M Bryant Howren, Donald M Lamkin, Jerry Suls. Psychosom Med 2009
23

Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies.
C A Köhler, T H Freitas, M Maes, N Q de Andrade, C S Liu, B S Fernandes, B Stubbs, M Solmi, N Veronese, N Herrmann,[...]. Acta Psychiatr Scand 2017
396
17

Inflammation and clinical response to treatment in depression: A meta-analysis.
R Strawbridge, D Arnone, A Danese, A Papadopoulos, A Herane Vives, A J Cleare. Eur Neuropsychopharmacol 2015
266
16

Cytokines sing the blues: inflammation and the pathogenesis of depression.
Charles L Raison, Lucile Capuron, Andrew H Miller. Trends Immunol 2006
15

The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.
Jonas Hannestad, Nicole DellaGioia, Michael Bloch. Neuropsychopharmacology 2011
526
15

Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder.
Rita Haapakoski, Julia Mathieu, Klaus P Ebmeier, Harri Alenius, Mika Kivimäki. Brain Behav Immun 2015
423
15

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
Charles L Raison, Robin E Rutherford, Bobbi J Woolwine, Chen Shuo, Pamela Schettler, Daniel F Drake, Ebrahim Haroon, Andrew H Miller. JAMA Psychiatry 2013
819
15

Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials.
Ole Köhler, Michael E Benros, Merete Nordentoft, Michael E Farkouh, Rupa L Iyengar, Ole Mors, Jesper Krogh. JAMA Psychiatry 2014
420
15

Cytokine-associated emotional and cognitive disturbances in humans.
A Reichenberg, R Yirmiya, A Schuld, T Kraus, M Haack, A Morag, T Pollmächer. Arch Gen Psychiatry 2001
844
14


The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
N Müller, M J Schwarz, S Dehning, A Douhe, A Cerovecki, B Goldstein-Müller, I Spellmann, G Hetzel, K Maino, N Kleindienst,[...]. Mol Psychiatry 2006
504
12

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Andrew A Nierenberg, Jonathan W Stewart, Diane Warden, George Niederehe, Michael E Thase, Philip W Lavori, Barry D Lebowitz,[...]. Am J Psychiatry 2006
12

Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy.
Paula Kopschina Feltes, Janine Doorduin, Hans C Klein, Luis Eduardo Juárez-Orozco, Rudi Ajo Dierckx, Cristina M Moriguchi-Jeckel, Erik Fj de Vries. J Psychopharmacol 2017
82
14

Depression as a microglial disease.
Raz Yirmiya, Neta Rimmerman, Ronen Reshef. Trends Neurosci 2015
323
12

Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study.
Seyed-Hesameddin Abbasi, Fahimeh Hosseini, Amirhossein Modabbernia, Mandana Ashrafi, Shahin Akhondzadeh. J Affect Disord 2012
177
10

CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies.
Vyara Valkanova, Klaus P Ebmeier, Charlotte L Allan. J Affect Disord 2013
451
10


Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.
Elaine Setiawan, Alan A Wilson, Romina Mizrahi, Pablo M Rusjan, Laura Miler, Grazyna Rajkowska, Ivonne Suridjan, James L Kennedy, P Vivien Rekkas, Sylvain Houle,[...]. JAMA Psychiatry 2015
386
10

Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis.
Cristiano A Köhler, Thiago H Freitas, Brendon Stubbs, Michael Maes, Marco Solmi, Nicola Veronese, Nayanna Q de Andrade, Gerwyn Morris, Brisa S Fernandes, André R Brunoni,[...]. Mol Neurobiol 2018
154
10

Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides.
Susana G Torres-Platas, Cristiana Cruceanu, Gary Gang Chen, Gustavo Turecki, Naguib Mechawar. Brain Behav Immun 2014
214
10



Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study.
Michael E Benros, Berit L Waltoft, Merete Nordentoft, Søren D Ostergaard, William W Eaton, Jesper Krogh, Preben B Mortensen. JAMA Psychiatry 2013
253
9




NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder.
Elísabet Alcocer-Gómez, Manuel de Miguel, Nieves Casas-Barquero, Jéssica Núñez-Vasco, José Antonio Sánchez-Alcazar, Ana Fernández-Rodríguez, Mario D Cordero. Brain Behav Immun 2014
197
8


Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis.
Klaus Munkholm, Julie Vestergaard Braüner, Lars Vedel Kessing, Maj Vinberg. J Psychiatr Res 2013
230
8

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial.
Shahin Akhondzadeh, Sara Jafari, Firoozeh Raisi, Abbas Ali Nasehi, Aboulfazl Ghoreishi, Bahman Salehi, Soodeh Mohebbi-Rasa, Maedeh Raznahan, Abbas Kamalipour. Depress Anxiety 2009
233
8

Immune disturbances during major depression: upregulated expression of interleukin-2 receptors.
M Maes, E Bosmans, E Suy, C Vandervorst, C De Jonckheere, J Raus. Neuropsychobiology 1990
117
8

The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery.
Johan Dahl, Heidi Ormstad, Hans Christian D Aass, Ulrik Fredrik Malt, Lil Träskman Bendz, Leiv Sandvik, Lena Brundin, Ole A Andreassen. Psychoneuroendocrinology 2014
179
8

Neuroimmune mechanisms of depression.
Georgia E Hodes, Veronika Kana, Caroline Menard, Miriam Merad, Scott J Russo. Nat Neurosci 2015
243
8

Social stress induces neurovascular pathology promoting depression.
Caroline Menard, Madeline L Pfau, Georgia E Hodes, Veronika Kana, Victoria X Wang, Sylvain Bouchard, Aki Takahashi, Meghan E Flanigan, Hossein Aleyasin, Katherine B LeClair,[...]. Nat Neurosci 2017
240
8



Cytokines and major depression.
Olga J G Schiepers, Marieke C Wichers, Michael Maes. Prog Neuropsychopharmacol Biol Psychiatry 2005
757
7

The HPA axis in major depression: classical theories and new developments.
Carmine M Pariante, Stafford L Lightman. Trends Neurosci 2008
980
7

An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
Rudolf Uher, Katherine E Tansey, Tracy Dew, Wolfgang Maier, Ole Mors, Joanna Hauser, Mojca Zvezdana Dernovsek, Neven Henigsberg, Daniel Souery, Anne Farmer,[...]. Am J Psychiatry 2014
191
7


Inflammation-associated depression: from serotonin to kynurenine.
Robert Dantzer, Jason C O'Connor, Marcus A Lawson, Keith W Kelley. Psychoneuroendocrinology 2011
428
7

Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression.
Ives Cavalcante Passos, Mirela Paiva Vasconcelos-Moreno, Leonardo Gazzi Costa, Maurício Kunz, Elisa Brietzke, João Quevedo, Giovanni Salum, Pedro V Magalhães, Flávio Kapczinski, Márcia Kauer-Sant'Anna. Lancet Psychiatry 2015
272
7

The molecular neurobiology of depression.
Vaishnav Krishnan, Eric J Nestler. Nature 2008
7

Inflammation in Depression and the Potential for Anti-Inflammatory Treatment.
Ole Kohler, Jesper Krogh, Ole Mors, Michael Eriksen Benros. Curr Neuropharmacol 2016
148
7

Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study.
D Gimeno, M Kivimäki, E J Brunner, M Elovainio, R De Vogli, A Steptoe, M Kumari, G D O Lowe, A Rumley, M G Marmot,[...]. Psychol Med 2009
322
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.